• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者发生超急性多器官血栓栓塞性风暴:病例报告

Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.

机构信息

Faculty of Medicine, McGill University, Montreal, Canada.

Department of Medicine, University of Montreal, Montreal, Canada.

出版信息

J Thromb Thrombolysis. 2021 Jan;51(1):25-28. doi: 10.1007/s11239-020-02173-w.

DOI:10.1007/s11239-020-02173-w
PMID:32506364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7275659/
Abstract

Acute viral pneumonia, hypoxemic respiratory failure and severe inflammatory response are hallmarks of severe coronavirus disease 2019 (COVID-19). The COVID-19-associated inflammatory state may further lead to symptomatic thromboembolic complications despite prophylaxis. We report a 66-year-old female patient with post-mortem diagnosis of COVID-19 who presented progressive livedo racemosa, acute renal failure and myocardial injury, as well as an absence of respiratory symptoms. Transthoracic echocardiography showed severe spontaneous echo contrast in the right cardiac chambers and right-sided cardiac overload presumed to result from pulmonary microvascular thrombosis or embolism. D-dimer levels were increased. The patient developed an acute ischemic stroke and died 2 days following presentation despite therapeutic anticoagulation. Her predominantly thromboembolic presentation supports the concept of coronavirus infection of endothelial cells and hypercoagulability, or COVID-19 endotheliitis. The case we report highlights that COVID-19-associated hyperacute multi-organ thromboembolic storm may precede or present disproportionately to respiratory involvement.

摘要

急性病毒性肺炎、低氧性呼吸衰竭和严重炎症反应是严重 2019 年冠状病毒病(COVID-19)的标志。COVID-19 相关的炎症状态可能会导致有症状的血栓栓塞并发症,尽管进行了预防。我们报告了一例 66 岁女性患者,COVID-19 死后诊断为进行性网状青斑、急性肾功能衰竭和心肌损伤,且无呼吸系统症状。经胸超声心动图显示右心腔和右侧心脏负荷严重自发性回声对比,推测是由于肺微血管血栓形成或栓塞所致。D-二聚体水平升高。尽管进行了治疗性抗凝,该患者仍在出现症状后 2 天发生急性缺血性卒中并死亡。她主要表现为血栓栓塞,支持冠状病毒感染内皮细胞和高凝状态,或 COVID-19 血管内皮炎的概念。我们报告的病例强调 COVID-19 相关的超急性多器官血栓栓塞风暴可能先于或不成比例地发生于呼吸受累。

相似文献

1
Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.COVID-19 患者发生超急性多器官血栓栓塞性风暴:病例报告
J Thromb Thrombolysis. 2021 Jan;51(1):25-28. doi: 10.1007/s11239-020-02173-w.
2
Aortic thrombus in patients with severe COVID-19: review of three cases.严重 COVID-19 患者的主动脉血栓:三例病例回顾。
J Thromb Thrombolysis. 2021 Jan;51(1):237-242. doi: 10.1007/s11239-020-02219-z.
3
Large Vessel Occlusion Secondary to COVID-19 Hypercoagulability in a Young Patient: A Case Report and Literature Review.一名年轻患者因新冠病毒感染高凝状态继发大血管闭塞:病例报告及文献综述
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105307. doi: 10.1016/j.jstrokecerebrovasdis.2020.105307. Epub 2020 Sep 10.
4
Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.严重 SARS-CoV-2 感染患者血浆 D-二聚体水平的改善可作为纤维蛋白溶解抑制的指标:病例报告。
Medicine (Baltimore). 2021 Apr 16;100(15):e25255. doi: 10.1097/MD.0000000000025255.
5
Venous thromboembolism and COVID-19: a case report and review of the literature.静脉血栓栓塞症与2019冠状病毒病:一例病例报告及文献综述
J Med Case Rep. 2020 Oct 15;14(1):188. doi: 10.1186/s13256-020-02516-4.
6
Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.COVID-19 感染患者的恶性大脑缺血:病例回顾与组织病理学发现。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105231. doi: 10.1016/j.jstrokecerebrovasdis.2020.105231. Epub 2020 Aug 5.
7
Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report.严重急性呼吸综合征冠状病毒 2 引起的急性主动脉闭塞:一例报告。
J Med Case Rep. 2021 Mar 2;15(1):112. doi: 10.1186/s13256-021-02692-x.
8
Anticoagulation for COVID-19 Patients: A Bird's-Eye View.COVID-19 患者的抗凝治疗:鸟瞰。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211039288. doi: 10.1177/10760296211039288.
9
Platelets and renal failure in the SARS-CoV-2 syndrome.血小板与 SARS-CoV-2 综合征所致肾衰竭。
Platelets. 2021 Jan 2;32(1):130-137. doi: 10.1080/09537104.2020.1817361. Epub 2020 Sep 6.
10
[Late occurrence of pulmonary embolsim in SARS-CoV-2 pneumonia: a case series].[新型冠状病毒肺炎中肺栓塞的晚期发生:病例系列]
G Ital Cardiol (Rome). 2020 Jul;21(7):523-525. doi: 10.1714/3386.33638.

引用本文的文献

1
Defining the short-term and long-term skin manifestations of COVID-19: insights after more than three years of the pandemic.定义 COVID-19 的短期和长期皮肤表现:大流行三年多后的洞察。
Rom J Morphol Embryol. 2023 Jul-Sep;64(3):291-304. doi: 10.47162/RJME.64.3.01.
2
Long-term cardio-vascular risk assessment in chronic kidney disease and kidney transplanted patients following SARS-COV-2 disease: protocol for multi-center observational match controlled trial.SARS-CoV-2 疾病后慢性肾脏病和肾移植患者的长期心血管风险评估:多中心观察性匹配对照试验方案。
BMC Nephrol. 2022 May 6;23(1):176. doi: 10.1186/s12882-022-02809-4.
3

本文引用的文献

1
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.COVID-19 患者接受抗栓治疗时的静脉血栓栓塞症的系统评估:发生率和 D-二聚体作为预测因素的作用。
J Thromb Thrombolysis. 2020 Jul;50(1):211-216. doi: 10.1007/s11239-020-02146-z.
2
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
3
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
COVID-19 and Acute Kidney Injury: A Systematic Review.
新型冠状病毒肺炎与急性肾损伤:一项系统综述
Front Med (Lausanne). 2022 Apr 4;9:705908. doi: 10.3389/fmed.2022.705908. eCollection 2022.
4
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.新型冠状病毒病和 SARS-CoV-2 疫苗接种中的凝血障碍和纤维蛋白溶解病理生理学。
Int J Mol Sci. 2022 Mar 19;23(6):3338. doi: 10.3390/ijms23063338.
5
Stroke Associated with SARS-CoV-2 Infection and its Pathogenesis: A Systematic Review.与SARS-CoV-2感染相关的中风及其发病机制:一项系统综述。
Basic Clin Neurosci. 2021 Sep-Oct;12(5):569-586. doi: 10.32598/bcn.2021.3277.1. Epub 2021 Sep 1.
6
Syncope and COVID-19 disease - A systematic review.晕厥与 COVID-19 疾病——系统综述。
Auton Neurosci. 2021 Nov;235:102872. doi: 10.1016/j.autneu.2021.102872. Epub 2021 Aug 27.
7
Cutaneous manifestations associated with COVID-19 in children: A systematic review.儿童新冠病毒感染相关的皮肤表现:一项系统综述。
J Family Med Prim Care. 2021 Jan;10(1):93-101. doi: 10.4103/jfmpc.jfmpc_1389_20. Epub 2021 Jan 30.
8
Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis.法布里病患者在 COVID-19 时代中风的风险增加。一个假设。
Med Hypotheses. 2020 Nov;144:110282. doi: 10.1016/j.mehy.2020.110282. Epub 2020 Sep 17.
9
Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers.COVID-19 成年患者的皮肤表现和医护人员中与 COVID-19 大流行相关的皮肤病。
Curr Allergy Asthma Rep. 2020 Oct 12;20(12):75. doi: 10.1007/s11882-020-00974-w.
10
Predictors of COVID-19 severity: A literature review.预测 COVID-19 严重程度的因素:文献综述。
Rev Med Virol. 2021 Jan;31(1):1-10. doi: 10.1002/rmv.2146. Epub 2020 Jul 30.
确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高:更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
4
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病:预防、抗栓治疗与随访的相关问题:美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
6
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
7
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.严重 COVID-19 感染发病机制中的补体相关微血管损伤和血栓形成:五例报告。
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
8
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
9
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms.血栓炎症:治疗性靶向凝血和其他宿主防御机制的挑战。
Blood. 2019 Feb 28;133(9):906-918. doi: 10.1182/blood-2018-11-882993. Epub 2019 Jan 14.
10
Spontaneous contrast in all cardiac chambers in a patient with a normal heart: case report with literature review.
Int J Cardiol. 2014 Jul 15;175(1):e19-20. doi: 10.1016/j.ijcard.2014.04.234. Epub 2014 Apr 28.